Saroglitazar improves transaminases and transient elastography in patients with diabetic dyslipidemia and non-alcoholic fatty liver disease

被引:0
|
作者
Goyal, Omesh [1 ]
Goyal, Prerna [1 ]
Nauhria, Sahil [1 ]
Kaur, Jaskirat [1 ]
Kumar, Paraag [1 ]
Chhina, Rajoo S. [1 ]
机构
[1] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PP 0608
引用
收藏
页码:378 / 378
页数:1
相关论文
共 50 条
  • [41] The impact of controlled attenuation parameter on liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver disease
    Lee, Dong Hyeon
    Kim, Won
    Jung, Yong Jin
    [J]. HEPATOLOGY, 2016, 64 : 539A - 539A
  • [42] Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist
    Honda, Akihiro
    Kamata, Shotaro
    Satta, Chihiro
    Machida, Yui
    Uchii, Kie
    Terasawa, Kazuki
    Nemoto, Ayane
    Oyama, Takuji
    Ishii, Isao
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (09) : 1210 - 1219
  • [43] Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Honda, Yasushi
    Yoneda, Masato
    Imajo, Kento
    Nakajima, Atsushi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 14
  • [44] Impact of Liver Histology on Hepatic Elastography in Non-alcoholic Fatty Liver Disease
    Palan, Ranesh
    Kemp, William W.
    DeBoer, Bastiaan
    Hamdorf, Jeffrey M.
    House, Michael J.
    MacQuillan, Gerry C.
    Garas, George
    Ching, Helena
    Mac Nicholas, Ross
    Roberts, Stuart K.
    Kitson, Matthew T.
    Jeffrey, Gary P.
    Adams, Leon
    [J]. HEPATOLOGY, 2014, 60 : 609A - 610A
  • [45] Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients
    Goh, George Boon-Bee
    Pagadala, Mangesh R.
    Dasarathy, Jaividhya
    Unalp-Arida, Aynur
    Sargent, Ruth
    Hawkins, Carol
    Sourianarayanane, Achuthan
    Khiyami, Amer
    Yerian, Lisa
    Pai, Rish K.
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    [J]. BBA CLINICAL, 2015, 3 : 141 - 145
  • [46] Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy
    Mikolasevic, Ivana
    Delija, Bozena
    Mijic, Ana
    Stevanovic, Tajana
    Skenderevic, Nadija
    Sosa, Ivan
    Krznaric-Zrnic, Irena
    Abram, Maja
    Krznaric, Zeljko
    Domislovic, Viktor
    Kanizaj, Tajana Filipec
    Radic-Kristo, Delfa
    Cubranic, Aleksandar
    Grubesic, Aron
    Nakov, Radislav
    Skrobonja, Ivana
    Stimac, Davor
    Hauser, Goran
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [47] New dual peroxisome proliferator activated receptor agonist—Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence
    Upendra Kaul
    Deven Parmar
    K. Manjunath
    Mitesh Shah
    Krupi Parmar
    Kishor P. Patil
    Ashok Jaiswal
    [J]. Cardiovascular Diabetology, 18
  • [48] SCREENING FOR NON-ALCOHOLIC FATTY LIVER DISEASE BY TRANSIENT ELASTOGRAPHY WITH CONTROLLED ATTENUATION PARAMETER IN UNSELECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Restellini, Sophie
    Palumbo, Chiara Saroli
    Chao, Che-yung
    Aruljothy, Achuthan
    Sebastiani, Giada
    Bessissow, Talat
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S976 - S976
  • [49] Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease
    Handzlik, Gabriela
    Holecki, Michal
    Kozaczka, Joanna
    Kukla, Michal
    Wyskida, Katarzyna
    Kedzierski, Leszek
    Pawlicki, Krzysztof
    Dulawa, Jan
    [J]. PHARMACOLOGICAL REPORTS, 2019, 71 (02) : 183 - 188
  • [50] Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease
    Gabriela Handzlik
    Michał Holecki
    Joanna Kozaczka
    Michał Kukla
    Katarzyna Wyskida
    Leszek Kędzierski
    Krzysztof Pawlicki
    Jan Duława
    [J]. Pharmacological Reports, 2019, 71 : 183 - 188